Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14867880 | Publishing Date : 06-Nov-2019 | No. of pages : 96
Detailed TOC of Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 CAR T-cell Therapy
1.4.3 TCR T-cell Therapy
1.5 Market by Application
1.5.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2019-2025)
1.5.2 Acute Lymphocytic Leukemia
1.5.3 Chronic Lymphocytic Leukemia
1.5.4 B Cell Lymphoma
1.5.5 Multiple Myeloma
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gene Modifying Immunotherapy for Blood Cancer Market Size
2.2 Gene Modifying Immunotherapy for Blood Cancer Growth Trends by Regions
2.2.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions (2019-2025)
2.2.2 Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by by Players
3.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Revenue by by Players (2014-2019)
3.1.2 Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by by Players (2014-2019)
3.1.3 Global Gene Modifying Immunotherapy for Blood Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Area Served
3.3 Key Players Gene Modifying Immunotherapy for Blood Cancer Product/Solution/Service
3.4 Date of Enter into Gene Modifying Immunotherapy for Blood Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2014-2019)
4.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2014-2019)
5 North America
5.1 North America Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
5.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in North America
5.3 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
5.4 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
6 Europe
6.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
6.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Europe
6.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
6.4 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
7 China
7.1 China Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
7.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in China
7.3 China Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
7.4 China Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
8 Japan
8.1 Japan Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
8.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Japan
8.3 Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
8.4 Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
9.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Southeast Asia
9.3 Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
9.4 Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
10 India
10.1 India Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
10.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in India
10.3 India Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
10.4 India Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019)
11.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Central & South America
11.3 Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type
11.4 Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.1.4 Novartis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019))
12.1.5 Novartis Recent Development
12.2 Kite Pharma
12.2.1 Kite Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.2.4 Kite Pharma Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.2.5 Kite Pharma Recent Development
12.3 Juno Therapeutics
12.3.1 Juno Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.3.4 Juno Therapeutics Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.3.5 Juno Therapeutics Recent Development
12.4 Cellectis
12.4.1 Cellectis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.4.4 Cellectis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.4.5 Cellectis Recent Development
12.5 Ziopharm Oncology
12.5.1 Ziopharm Oncology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.5.4 Ziopharm Oncology Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.5.5 Ziopharm Oncology Recent Development
12.6 Celyad
12.6.1 Celyad Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.6.4 Celyad Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.6.5 Celyad Recent Development
12.7 Bluebird Bio
12.7.1 Bluebird Bio Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.7.4 Bluebird Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.7.5 Bluebird Bio Recent Development
12.8 Bellicum Pharmaceuticals
12.8.1 Bellicum Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.8.4 Bellicum Pharmaceuticals Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.8.5 Bellicum Pharmaceuticals Recent Development
12.9 Mustang Bio
12.9.1 Mustang Bio Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gene Modifying Immunotherapy for Blood Cancer Introduction
12.9.4 Mustang Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
12.9.5 Mustang Bio Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Gene Modifying Immunotherapy for Blood Cancer Key Market Segments
Table Key Players Gene Modifying Immunotherapy for Blood Cancer Covered
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer CAR T-cell Therapy Figures
Table Key Players of CAR T-cell Therapy
Figuer TCR T-cell Therapy Figures
Table Key Players of TCR T-cell Therapy
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Application in 2018 & 2025
Figure Acute Lymphocytic Leukemia Case Studies
Figure Chronic Lymphocytic Leukemia Case Studies
Figure B Cell Lymphoma Case Studies
Figure Multiple Myeloma Case Studies
Figure Other Case Studies
Figure Gene Modifying Immunotherapy for Blood Cancer Report Years Considered
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions 2019-2025 (Million US$)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions 2019-2025 (Million US$)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions 2014-2019
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions 2014-2019
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Gene Modifying Immunotherapy for Blood Cancer Revenue by by Players (2014-2019) (Million US$)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Share by by Players (2014-2019)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by by Players in 2018
Table Global Gene Modifying Immunotherapy for Blood Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gene Modifying Immunotherapy for Blood Cancer Product/Solution/Service
Table Date of Enter into Gene Modifying Immunotherapy for Blood Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Type (2014-2019)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2014-2019)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Application (2014-2019)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2014-2019)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Application in 2018
Figure North America Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table North America Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table North America Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Figure Europe Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Figure China Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table China Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table China Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table China Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table China Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Figure Japan Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Figure Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Figure India Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table India Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table India Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table India Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table India Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Figure Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019)
Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$)
Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019
Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$)
Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019
Table Novartis Company Details
Table Novartis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Novartis Recent Development
Table Kite Pharma Company Details
Table Kite Pharma Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Kite Pharma Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Kite Pharma Recent Development
Table Juno Therapeutics Company Details
Table Juno Therapeutics Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Juno Therapeutics Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Juno Therapeutics Recent Development
Table Cellectis Company Details
Table Cellectis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Cellectis Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Cellectis Recent Development
Table Ziopharm Oncology Company Details
Table Ziopharm Oncology Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Ziopharm Oncology Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Ziopharm Oncology Recent Development
Table Celyad Company Details
Table Celyad Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Celyad Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Celyad Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Bluebird Bio Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Bluebird Bio Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Bellicum Pharmaceuticals Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Mustang Bio Company Details
Table Mustang Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$)
Figure Mustang Bio Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)
Table Mustang Bio Recent Development
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Regions (2019-2025)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Regions in 2025
Figure North America Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Product (2019-2025)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Product in 2025
Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2019-2025)
Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2019-2025
NovartisKite Pharma
Juno Therapeutics
Cellectis
Ziopharm Oncology
Celyad
Bluebird Bio
Bellicum Pharmaceuticals
Mustang Bio